Organism name | Magnolia officinalis |
---|---|
Genus | Magnolia |
Family | Magnoliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Magnolia officinalis |
---|---|
Linked NCBI taxonomy ID | 85864 |
Linked level | species |
Family in NCBI taxonomy | Magnoliaceae |
---|---|
ID | 3401 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Magnoliophyta |
---|---|
ID | 3398 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00034404
![]() |
Aceoside
|
CHEMBL449185
|
No. 17 | No. 11 |
![]() |
|||
C00002783
![]() |
Kusaginin
/ Acteoside / Verbascoside |
CHEMBL231853
CHEMBL444478 CHEMBL1364101 |
C058956
|
12 / 1 / 1 | 34 / 3 | No. 33 |
![]() |
|
C00002631
![]() |
(+)-Lirioresinol B
/ (+)-Syringaresinol |
CHEMBL361362
CHEMBL402653 |
C042192
|
1 / 0 / 0 | No. 38 | No. 21 |
![]() |
|
C00002728
![]() |
Coniferaldehyde
/ Coniferyl aldehyde / 4-Hydroxy-3-methoxycinnamaldehyde |
CHEMBL242529
CHEMBL1956165 |
C075384
|
1 / 1 / 1 | No. 310 | No. 6 |
![]() |
|
C00000010
![]() |
Syringin
|
CHEMBL250872
|
C028305
|
1 / 0 / 0 | 0 / 1 | No. 678 | No. 6 |
![]() |
C00030708
![]() |
Magnaldehyde E
|
CHEMBL251060
|
No. 761 | No. 23 |
![]() |
|||
C00040486
![]() |
threo-Honokitriol
/ (+)-threo-Honokitriol |
No. 761 | No. 23 |
![]() |
||||
C00040143
![]() |
Randaiol
|
CHEMBL555924
|
No. 761 | No. 23 |
![]() |
|||
C00030707
![]() |
Magnaldehyde B
|
CHEMBL250885
|
No. 761 | No. 23 |
![]() |
|||
C00002609
![]() |
Hinokiol
/ (+)-Hinokiol |
CHEMBL16901
|
26 / 24 / 20 | No. 761 | No. 23 |
![]() |
||
C00030709
![]() |
Magnolignan C
/ (-)-Magnolignan C |
CHEMBL399697
|
No. 761 | No. 23 |
![]() |
|||
C00000591
![]() |
Magnolol
|
CHEMBL180920
|
C005498
|
21 / 17 / 15 | 1 / 7 | No. 761 | No. 23 |
![]() |
C00039712
![]() |
Magnolignan B
|
No. 761 | No. 23 |
![]() |
||||
C00039166
![]() |
erythro-Honokitriol
/ (-)-erythro-Honokitriol |
No. 761 | No. 23 |
![]() |
||||
C00007558
![]() |
Syringaldehyde
/ 4-Hydroxy-3,5-dimethoxybenzaldehyde |
CHEMBL225303
|
C069665
|
No. 856 |
![]() |
|||
C00024183
![]() |
Obovatol
|
CHEMBL491809
|
C036795
|
No. 3309 |
![]() |
|||
C00039710
![]() |
Magnatriol B
|
No. 6327 |
![]() |
|||||
C00039711
![]() |
Magnolianone
|
No. 8461 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q99700 | Ataxin-2 | Unclassified protein | C00000591 C00002609 C00002783 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00000591 C00002609 C00002783 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002609 C00002783 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000591 C00002609 | 2 / 5 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000591 C00002609 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000591 C00002783 | 0 / 0 |
Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00000591 C00002609 | 1 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000591 C00002609 | 4 / 3 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000591 C00002609 | 1 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000591 C00002609 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00000591 C00002609 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00000591 C00002609 | 1 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000591 C00002609 | 0 / 0 |
Q9Y2T6 | G-protein coupled receptor 55 | Lysophosphatidylinositol receptor | C00000591 C00002609 | 0 / 0 |
P34972 | Cannabinoid receptor 2 | Cannabinoid receptor | C00000591 C00002609 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000591 C00002609 | 2 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002609 C00002783 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002783 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000591 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000591 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000010 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002609 | 2 / 2 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002783 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002783 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002609 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002609 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002609 | 5 / 3 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002609 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000591 | 2 / 2 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002783 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000591 | 1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002728 | 1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002609 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00002609 | 4 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002609 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002783 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000591 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002783 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002609 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002609 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002783 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000591 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000591
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00002783
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00002783
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002783
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002783
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00002783
|
896 | CCND3 | cyclin D3 |
C00002783
|
898 | CCNE1, CCNE | cyclin E1 |
C00002783
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00002783
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002783
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002783
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002783
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002783
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00002783
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002783
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00002783
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002783
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002783
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00002783
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002783
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002783
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00002783
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002783
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002783
|
27035 | NOX1, GP91-2, MOX1, NOH-1, NOH1 | NADPH oxidase 1 |
C00002783
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002783
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002783
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002783
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00002783
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00002783
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002783
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00002783
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00002783
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002783
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002783
|
OMIM | preferred title | UniProt |
---|---|---|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
%606641 | Body mass index; bmi |
P37231
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#114500 | Colorectal cancer; crc |
P84022
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P37231
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278300 | Xanthinuria, type i |
P47989
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D002545 | Brain Ischemia |
C00000591
|
D056486 | Drug-Induced Liver Injury |
C00000591
|
D005334 | Fever |
C00000591
|
D018883 | Heat Stroke |
C00000591
|
D009203 | Myocardial Infarction |
C00000591
|
D017180 | Tachycardia, Ventricular |
C00000591
|
D014693 | Ventricular Fibrillation |
C00000591
|
D001862 | Bone Resorption |
C00000010
|
D007249 | Inflammation |
C00002783
|
D007938 | Leukemia |
C00002783
|
D014947 | Wounds and Injuries |
C00002783
|